Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,296	65	17	29	139	82
Market Cap Growth	19003.69%	291.57%	-42.14%	-79.41%	70.05%	-12.98%
Enterprise Value	1,259	32	-8	-16	62	7
PE Ratio	-	-0.70	7.22	-0.33	-2.48	-1.49
PS Ratio	9.22	0.57	0.16	3.91	6.66	-
PB Ratio	22.89	-4.11	0.39	0.70	1.83	1.20
P/FCF Ratio	48.09	3.61	2.92	-0.34	-2.52	-1.88
P/OCF Ratio	37.05	2.51	1.56	-0.34	-2.53	-1.88
EV/Sales Ratio	8.95	0.28	-0.08	-2.15	2.95	-
EV/EBITDA Ratio	-20.04	-0.38	-0.89	0.18	-1.10	-0.13
EV/EBIT Ratio	-19.52	-0.38	-1.07	0.18	-1.10	-0.13
EV/FCF Ratio	46.71	1.77	-1.40	0.19	-1.12	-0.16
Debt / Equity Ratio	0.00	-0.03	0.01	0.06	0.02	0.03
Debt / EBITDA Ratio	0.00	0.00	0.07	-0.03	-0.03	-0.03
Debt / FCF Ratio	0.01	0.02	0.11	-0.03	-0.03	-0.04
Quick Ratio	3.02	2.75	3.46	3.44	4.65	3.18
Current Ratio	3.22	2.85	4.06	3.63	5.03	3.32
Asset Turnover	2.16	2.88	1.71	0.08	0.19	0
Return on Equity (ROE)	-2139.50%	558.30%	5.20%	-120.80%	-59.70%	-63.30%
Return on Assets (ROA)	-131.30%	-235.80%	3.80%	-99.10%	-51.00%	-54.80%
Return on Capital (ROIC)	-104.26%	436.02%	6.64%	-202.18%	-73.82%	-81.66%
Earnings Yield	-6.61%	-142.88%	13.86%	-306.30%	-40.33%	-67.29%
FCF Yield	2.08%	27.73%	34.27%	-294.67%	-39.67%	-53.27%
Dividend Yield	0.00%	14.00%	271.10%	0.00%	0.00%	0.00%
Payout Ratio	0.00%	-255.30%	53625.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-30.00%	13.02%	-3605.16%	-59.76%	-59.77%	-7.05%
Total Shareholder Return	-30.00%	27.02%	-3334.06%	-59.76%	-59.77%	-7.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).